GlassScriptPhysician profile
Denise Fiore
NPI 1750737870
$361.87
in general payments reported to CMS, 2019-2025
13 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.48 · 2022: $14.63 · 2024: $57.67 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $69.00 | 2021-2025 | Latitude Communicator Power Supply |
| Baxter Healthcare | $50.38 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Scpharmaceuticals INC. | $34.48 | 2025 | |
| Merck Sharp & Dohme LLC | $33.54 | 2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.44 | 2025 | Jardiance |
| Cvrx, INC. | $25.00 | 2024 | Barostim Neo System |
| Abbott Laboratories | $20.87 | 2025 | Cardiomems |
| Bayer Healthcare Pharmaceuticals INC. | $17.76 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $16.53 | 2024 | |
| Abbvie INC. | $16.22 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $16.14 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $14.88 | 2025 | Assure Wcd |
| Philips North America LLC | $14.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Fiore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.